期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Pharmacological Reports LetPub Score 6.3
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 7.0 | ||||||||||||||||
期刊簡稱 | PHARMACOL REP | ||||||||||||||||
ISSN | 1734-1140 | ||||||||||||||||
E-ISSN | 2299-5684 | ||||||||||||||||
h-index | 71 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.springer.com/43440 | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/prep/default.aspx | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Springer International Publishing | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | POLAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 2009 | ||||||||||||||||
每年文章數 | 114每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 42.82% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1734-1140%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 6.0 month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Pharmacological Reports] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:05:26 評論於 Afterwards, comparison is the testing of non-research hypotheses. It is very common in actual research: I have completed the experiment, verified the hypothesis, but still need to extend the research, which requires further exploration of the data to see which direction will yield valuable conclusions. At this point, it is as if I am testing all possible comparisons (even though I may not actually exhaust all comparisons, but because there is no specific purpose, all comparisons are potential). Because comparison does not only refer to the difference in means of two treatments, linear combinations of multiple treatments are also comparisons(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:11:39 評論於 Choose the post hoc test method based on the data results obtained(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 20:07:14 評論於 Why do we need to conduct post-inspections?(0) 讚! | 上清雨真 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:10:01 評論於 What kind of post-test should I use?(0) 讚! | 北国博达 |
作者: 八荒沛容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-12-05 10:38:38 評論於 Shouldn't it be $3000 directly? I saw it on the official website(0) 讚! | 八荒沛容 |
作者: 宗室向凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-12-03 21:01:42 評論於 How is the layout fee calculated?(0) 讚! | 宗室向凝 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 19:32:18 評論於 There has been an increase, optimistic about the future, what do you think?(0) 讚! | 凌霄高洁 |
作者: 白卉大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-02-10 11:23:23 評論於 Review speed: 1.0 | Submission acceptance rate: 75.0 Sharing experience: The journal editor is very meticulous and patient in helping to make some revisions, and another paper was accepted today(0) 讚! | 白卉大叔 |
作者: 白卉大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-11-04 09:19:37 評論於 Review Speed: 3.0 Experience sharing: I received an acceptance email yesterday (2015.11.3) for a bimonthly journal, but I am not sure when it will be published online(0) 讚! | 白卉大叔 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2012-08-27 19:41:00 評論於 This journal is a bimonthly journal. The first review is slow, it takes about 3-4 months, but the editor is very polite. The main publication focuses on molecular pharmacology research. As long as the research is creative, and the English writing is OK, you should be okay (0) 讚! | 匿名 |
作者: 墟散远骞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-08-27 10:46:45 評論於 The magazine is a bimonthly publication, with a slow review speed of about 3-4 months, but the editors are very polite. It mainly publishes research on molecular pharmacology, and as long as the research is creative and well-written in English, papers that are not in a rush to be published can choose to submit to this journal(0) 讚! | 墟散远骞 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-01-10 10:09:28 評論於 It's a long period of time(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-10-06 23:10:51 評論於 I submitted an article this year, but it was rejected after the initial review that lasted for 5 months(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-04-19 19:26:59 評論於 Review Speed: 6.0 Sharing of Experience: I submitted a paper last year, which went through a nearly 3-month initial review and major revisions. However, it was accepted after the revisions. Personally, I feel that the editor was very kind(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-12-03 13:05:46 評論於 Bi-monthly, very slow. First review cycle takes over 3 months(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us